Jie Jia

Company: Grit Biotechnology

Job title: Chief Operating Officer

Seminars:

Off-the-Shelf Allogeneic Cell Therapy in Autoimmune Diseases & Cancers 1:30 pm

Optimizing γ CAR-T manufacturing processes to produce ~1,000 doses with high purity and CAR expression Discussing how γ CAR-T products with armored CAR design achieves comparable tumor serial killing in vitro and superior tumor clearance in vivo compared to γγ CAR-T In vivo CAR-T therapy by T cell-targeted LNP delivery achieves complete Nalm-6 tumor control…Read more

day: Day One - Track B PM